Alessandra Chirco

ORCID: 0000-0001-5008-3201
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Economic theories and models
  • Merger and Competition Analysis
  • Economic Theory and Policy
  • Consumer Market Behavior and Pricing
  • Digital Platforms and Economics
  • Income, Poverty, and Inequality
  • Complex Systems and Time Series Analysis
  • Economic Theory and Institutions
  • Monetary Policy and Economic Impact
  • Game Theory and Applications
  • Economic Policies and Impacts
  • Economics of Agriculture and Food Markets
  • HER2/EGFR in Cancer Research
  • Auction Theory and Applications
  • Italy: Economic History and Contemporary Issues
  • Corporate Taxation and Avoidance
  • Fiscal Policy and Economic Growth
  • Cancer Immunotherapy and Biomarkers
  • BRCA gene mutations in cancer
  • Cancer Risks and Factors
  • Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Optical Coherence Tomography Applications
  • Optimization and Variational Analysis
  • Biosimilars and Bioanalytical Methods

University of Salento
2008-2025

Ospedale Papa Giovanni XXIII
2016-2024

Medica (Italy)
2023

Eli Lilly (United States)
2020

Novartis (France)
2020

Pfizer (United States)
2020

Pfizer (United Kingdom)
2020

Roche (Switzerland)
2020

AstraZeneca (Brazil)
2020

Genomic Health (United States)
2020

Matteo Lambertini Eva Blondeaux Elisa Agostinetto Anne-Sophie Hamy Hee Jeong Kim and 95 more Antonio Di Meglio Rinat Bernstein‐Molho Florentine Hilbers Katarzyna Pogoda Estela Carrasco Kevin Punie Jyoti Bajpai Michail Ignatiadis Halle C. F. Moore Kelly‐Anne Phillips Angela Toss Christine Rousset‐Jablonski Fedro A. Peccatori Tiphaine Renaud Alberta Ferrari Shani Paluch‐Shimon Robert Fruscio Wanda Cui Stephanie M. Wong Claudio Vernieri Kathryn J. Ruddy Maria Vittoria Dieci Alexios Matikas Mariya Rozenblit Cynthia Villarreal‐Garza Laura De Marchis Lucia Del Mastro Fabio Puglisi Maria Del Pilar Estevez Diz Kenny A. Rodriguez‐Wallberg Bela Mriňáková Sarah Meister Luca Livraghi Florian Clatot Rinat Yerushalmi Carmine De Angelis Rodrigo Sánchez-Bayona Icro Meattini Natalia Cichowska-Cwalińska Martine Berlière Mahmoud Salama Ugo De Giorgi Amir Sonnenblick Camila Chiodi Young‐Jin Lee Camille Maria Hatem A. Azim Luca Boni Ann H. Partridge Evandro de Azambuja Chiara Molinelli Marianne Paesmans Lieveke Ameye Frédéric Amant Hilde Brems Sileny Han Sigrid Hatse Ines Nevelsteen Patrick Neven Ann Smeets Chantal Van Rompuy Hans Wildiers François Duhoux Federica Giugliano Carmen Criscitiello Roberto Borea Luca Arecco Alessandra Chirco Federica Bini Marta Venturelli Laura Cortesi Riccardo Ponzone Nicoletta Tomasi Cont Judith Balmañà Rossella Graffeo Helena Luna Pais Alejandro Mohar Tamara Palacios Lucia Da Ros Gianmaria Miolo Mattia Garutti Brenno Pastò Simon Spazzapan Alessandra Viel José Alejandro Pérez Fidalgo Renata Colombo Bonadio Tamar Peretz‐Yablonski Chiara Annunziata Pasqualina Anghelone Angelica Della Valle Maria Campanella Valentina Guarneri Raphaëlle Bas Pierre-Étienne Heudel Olivier Trédan Solenne de Talouet

Importance Young women with breast cancer who have germline pathogenic variants in BRCA1 or BRCA2 face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy survivors included limited data BRCA carriers. Objective To investigate cumulative incidence disease-free survival young are Design, Setting, Participants International, multicenter, hospital-based, retrospective cohort study conducted at 78 participating centers worldwide. The...

10.1001/jama.2023.25463 article EN JAMA 2023-12-07

Abstract Background Breast cancer (BC) in women aged ≤40 years carrying germline pathogenetic variants (PVs) BRCA1/2 genes is infrequent but often associated with aggressive features. Human epidermal growth factor receptor 2 (HER2)‐low‐expressing BC has recently emerged as a novel therapeutic target not been characterized this rare patient subset. Methods Women newly diagnosed early‐stage HER2‐negative (HER2‐0 and HER2‐low) PVs from 78 health care centers worldwide were retrospectively...

10.1002/cncr.35323 article EN cc-by-nc-nd Cancer 2024-05-16

Abstract The question raised in this paper is whether and how some core features of income distribution, e.g. the levels or inequality, should be relevant decision to privatize public firms. provides a first answer framework mixed oligopoly theory. In particular, we show that scope for privatization widened when market poorer, incomes become more concentrated. These unexpected results are accounted terms way distributional shocks alter allocative inefficiency imperfectly competitive markets.

10.1007/s00712-025-00899-w article EN cc-by Journal of Economics 2025-02-07

We investigate how market competition affects the incentive to adopt a non-profit-maximizing behaviour. The analysis is developed in strategic delegation framework which owners delegate output decisions managers interested firm's relative performance. study optimal scheme affected by concentration and elasticity of demand. prove that distortion from profit-maximizing rule decreases as becomes less concentrated, while it increases demand more elastic. Finally, we discuss impact...

10.1111/j.1467-999x.2011.04124.x article EN Metroeconomica 2011-05-23

The paper analyses the effects of income concentration on behaviour a duopoly with vertical product differentiation and uncovered market. By using trapezoid distribution, we solve explicitly for market equilibrium as function mean preserving spread distribution. We show that overall more concentrated incomes imply stronger differentiation, presence large share middle-income consumers stimulates price competition, whose are dampened through an enlargement quality spread. While high-quality...

10.1111/j.0307-3378.2006.00249.x article EN Bulletin of Economic Research 2006-10-01

In Europe, the SARS-CoV-2 pandemic had its first epicenter in Italy. Despite a significant mortality rate, severity of most cases COVID-19 infection ranges from asymptomatic to mildly symptomatic, and silent affects still-unknown proportion general population. No information is available on prevalence clinical impact among patients with cancer receiving anticancer treatment during pandemic.

10.1002/onco.13654 article EN other-oa The Oncologist 2020-12-24

10.1007/s00355-006-0089-z article EN Social Choice and Welfare 2006-03-27

Background: Meningeal carcinomatosis is rare in patients with kidney cancer and treatment options are limited. Few treated systemic approaches have been reported. We describe a case of complete remission leptomeningeal metastasis patient renal cell carcinoma nivolumab. To our knowledge, this the first report nivolumab safety efficacy particular site metastasis. Case presentation: Our was 60-year-old Caucasian man bone lung metastases from carcinoma. He developed progression lesions after...

10.1177/0300891620904411 article EN Tumori Journal 2020-02-11

Abstract Income distribution affects market demand and its elasticity, and, as a consequence, the optimal behaviour of firms equilibrium. This paper focuses on effects income polarization, presents model where ± for any unimodal density function describing consumers polarization leads to concentration, i.e., smaller number able survive in long run, provided that firms' fixed costs are sufficiently low.

10.1111/1468-0475.00062 article EN German Economic Review 2002-08-01

We introduce non-homothetic preferences in the Dixit–Stiglitz model of monopolistic competition, and enquire about effects a change income dispersion on firms’ optimal decisions market equilibrium. Income dispersion, modeled as mean preserving spread, is shown to affect only degree product differentiation under standard negligibility hypothesis decision making process, while it generates positive co-movement demand elasticity, when this assumption removed price index effect taken into account.

10.1111/j.1467-999x.2005.00218.x article EN Metroeconomica 2005-07-01

Abstract. We investigate the bearings of level demand on firms' optimal locations and prices in a linear model spatial differentiation with quadratic disutility transportation. show that affects both firms, firms increase product only if is high enough to trigger price war. Otherwise, non-cooperative duopoly equilibrium observationally equivalent monopoly optimum same number products. Contrary transportation cost case, are everywhere increasing reservation price.

10.1007/s10110-003-0173-z article EN cc-by-nc-nd Papers of the Regional Science Association 2003-10-01

In The Economics of Imperfect Competition , Joan Robinson argued that an increase the consumers’ incomes should make demand less elastic—which, although reasonable about individual as assumption on preferences, suggests a role for income distribution far market is concerned. We use Esteban's ( International Economic Review Vol. 27 (1986), No. 2, pp. 439–444) share elasticity to provide sufficient conditions support ‘Robinson effect’—i.e. such negative (positive) relationship between and...

10.1111/j.1467-9957.2004.00410.x article EN Manchester School 2004-07-28
Coming Soon ...